Vericel Corporation (VCEL)
NASDAQ: VCEL · Real-Time Price · USD
39.03
-0.40 (-1.01%)
At close: Nov 18, 2025, 4:00 PM EST
39.03
0.00 (0.00%)
After-hours: Nov 18, 2025, 4:10 PM EST
Vericel Employees
Vericel had 357 employees as of December 31, 2024. The number of employees increased by 43 or 13.69% compared to the previous year.
Employees
357
Change (1Y)
43
Growth (1Y)
13.69%
Revenue / Employee
$724,697
Profits / Employee
$36,644
Market Cap
1.97B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 357 | 43 | 13.69% |
| Dec 31, 2023 | 314 | 9 | 2.95% |
| Dec 31, 2022 | 305 | 24 | 8.54% |
| Dec 31, 2021 | 281 | 8 | 2.93% |
| Dec 31, 2020 | 273 | 32 | 13.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VCEL News
- 4 days ago - Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025 - GlobeNewsWire
- 12 days ago - Vericel Corporation (VCEL) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Vericel Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025 - GlobeNewsWire
- 3 months ago - Vericel Corporation (VCEL) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Vericel Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025 - GlobeNewsWire
- 5 months ago - Vericel Corporation: Moving From Sell To Neutral - Seeking Alpha